HK1021314A1 - Formulation for the treatment and/or prophylaxis of dementia - Google Patents

Formulation for the treatment and/or prophylaxis of dementia

Info

Publication number
HK1021314A1
HK1021314A1 HK99105593A HK99105593A HK1021314A1 HK 1021314 A1 HK1021314 A1 HK 1021314A1 HK 99105593 A HK99105593 A HK 99105593A HK 99105593 A HK99105593 A HK 99105593A HK 1021314 A1 HK1021314 A1 HK 1021314A1
Authority
HK
Hong Kong
Prior art keywords
dementia
prophylaxis
formulation
treatment
Prior art date
Application number
HK99105593A
Other languages
English (en)
Inventor
Dirk M J Van Schie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1021314A1 publication Critical patent/HK1021314A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK99105593A 1996-07-25 1999-12-01 Formulation for the treatment and/or prophylaxis of dementia HK1021314A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615628.6A GB9615628D0 (en) 1996-07-25 1996-07-25 Formulation
PCT/EP1997/003872 WO1998004258A1 (en) 1996-07-25 1997-07-14 Formulation for the treatment and/or prophylaxis of dementia

Publications (1)

Publication Number Publication Date
HK1021314A1 true HK1021314A1 (en) 2000-06-09

Family

ID=10797487

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99105593A HK1021314A1 (en) 1996-07-25 1999-12-01 Formulation for the treatment and/or prophylaxis of dementia

Country Status (24)

Country Link
EP (1) EP0918521B1 (de)
JP (1) JP2000515868A (de)
KR (1) KR20000029523A (de)
CN (1) CN1226163A (de)
AR (1) AR007983A1 (de)
AT (1) ATE224711T1 (de)
BR (1) BR9710546A (de)
CA (1) CA2261233A1 (de)
CO (1) CO5031290A1 (de)
CZ (1) CZ22799A3 (de)
DE (1) DE69715878T2 (de)
DK (1) DK0918521T3 (de)
ES (1) ES2184121T3 (de)
GB (1) GB9615628D0 (de)
HK (1) HK1021314A1 (de)
IL (1) IL128095A (de)
NO (1) NO990283L (de)
NZ (1) NZ333704A (de)
PL (1) PL331283A1 (de)
PT (1) PT918521E (de)
TR (1) TR199900141T2 (de)
TW (1) TW426514B (de)
WO (1) WO1998004258A1 (de)
ZA (1) ZA976592B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815383D0 (en) * 1998-07-15 1998-09-16 Smithkline Beecham Plc Novel method of treatment
AU2002211067A1 (en) * 2000-09-27 2002-04-08 Dsm N.V. Process for the carbonylation of a conjugated diene
GB0428170D0 (en) * 2004-12-23 2005-01-26 Biopartners Ltd Mono and Combination Therapy
JP7293560B2 (ja) 2017-12-29 2023-06-20 グアンジョウ マキシノベル ファーマシューティカルズ カンパニー リミテッド 芳香族ビニルまたは芳香族エチル系誘導体、その製造方法、中間体、薬物組成物および使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392803B1 (de) * 1989-04-13 2004-06-16 Beecham Group p.l.c. Chemische Verbindungen
MX9300875A (es) * 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
AR007983A1 (es) 1999-11-24
NO990283L (no) 1999-03-19
KR20000029523A (ko) 2000-05-25
PT918521E (pt) 2003-02-28
IL128095A (en) 2002-07-25
DK0918521T3 (da) 2003-02-03
TR199900141T2 (xx) 1999-03-22
JP2000515868A (ja) 2000-11-28
BR9710546A (pt) 1999-08-17
CZ22799A3 (cs) 1999-06-16
NZ333704A (en) 2000-06-23
IL128095A0 (en) 1999-11-30
GB9615628D0 (en) 1996-09-04
CO5031290A1 (es) 2001-04-27
CA2261233A1 (en) 1998-02-05
CN1226163A (zh) 1999-08-18
ATE224711T1 (de) 2002-10-15
TW426514B (en) 2001-03-21
WO1998004258A1 (en) 1998-02-05
DE69715878D1 (de) 2002-10-31
ZA976592B (en) 1999-03-04
EP0918521B1 (de) 2002-09-25
AU721101B2 (en) 2000-06-22
AU3768497A (en) 1998-02-20
DE69715878T2 (de) 2003-05-22
ES2184121T3 (es) 2003-04-01
EP0918521A1 (de) 1999-06-02
NO990283D0 (no) 1999-01-22
PL331283A1 (en) 1999-07-05

Similar Documents

Publication Publication Date Title
EP0717592A4 (de) Verfahren und zusammensetzung zur behandlung des apathie-demotivations-syndroms
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
HU9802721D0 (en) Method and composition for the treatment and prevention of hyperuricemia
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
IL128379A0 (en) Treatment of the common cold or allergic rhinitis
ZA9610901B (en) Treatment and prophylaxis of osteoporosis
AU6946594A (en) Methods for the treatment and prevention of diarrhea
IL104940A0 (en) Method and composition for the treatment of osteoporosis
GB2314273B (en) The use of TCET in the prophylaxis and treatment of allergies
IL116142A0 (en) Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
AU1556497A (en) Agents for the treatment and prevention of aids
IL114119A0 (en) Compositions and methods for the treatment of tumors
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
AU2843397A (en) Agent for prophylaxis and treatment of disturbance of visual function
EP0642337A1 (de) Dapsone und promin zur behandlung der demenz.
IL128095A0 (en) Formulation for the treatment and/or prophylaxis of dementia
EP0688225A4 (de) Methoden und zusammensetzungen zur inhibierung der komplementaktivierung
GB2310619B (en) Surface treatment of screw parts
SI0918521T1 (en) Formulation for the treatment and/or prophylaxis of dementia
GB9726223D0 (en) The treatment of materials
AU2068395A (en) Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne
GB9317943D0 (en) Treatment of laminitis
EP0865292A4 (de) Zusammensetzungen und verfahren zur prävention und behandlung oraler mucositis
AU4391093A (en) Compositions and methods for the prevention and treatment of thrombosis
AUPM421894A0 (en) Method and composition for the prevention and/or treatment of ulcers

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060714